Company / EPS (Basic)
Edesa Biotech, Inc. EPS (Basic) History
FY2015-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.11
FY2016
5-year range
-$1.11 / -$1.11
FY2015-FY2016
Trend
+60.5%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1.11 in FY2016.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, eps (basic) increased 60.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | - | - |
| FY2020 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$1.11 | +60.5% |
| FY2015 | -$2.81 | - |
| FY2014 | - | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026